Non-PMI (n = 333) | PMI (n = 211) | P | |
---|---|---|---|
Clinical characteristics | |||
Male (%) | 231 (69.4%) | 147 (69.6%) | 0.941 |
Age (year) | 62.9 ± 9.1 | 66.4 ± 9.3 | <0.01 |
Hypertension (%) | 215 (64.6%) | 151 (71.6%) | 0.090 |
Hyperlipidemia (%) | 102 (30.6%) | 71 (33.6%) | 0.674 |
Diabetes (%) | 73 (22.0%) | 64 (30.3%) | 0.028 |
Smoking (%) | 140 (41.4%) | 73 (34.6%) | 0.088 |
LVEF (%) | 62.4 ± 6.7 | 60.3 ± 5.8 | 0.542 |
Systolic blood pressure (mmHg) | 127.8 ± 13.8 | 133.2 ± 15.9 | 0.105 |
Diastolic blood pressure (mmHg) | 76.3 ± 8.3 | 75.2 ± 8.1 | 0.544 |
Heart rate (beat per minute) | 69 ± 11 | 70 ± 8 | 0.802 |
Laboratory characteristics | |||
eGFR (ml/min) | 94.4 ± 20.4 | 92.6 ± 22.6 | 0.486 |
Total cholesterol (mmol/L) | 3.98 ± 1.02 | 4.26 ± 1.44 | 0.018 |
Triglyceride (mmol/L) | 1.85 ± 0.96 | 2.04 ± 1.89 | 0.102 |
Pre-procedural CK-MB (U/L) | 12.4 ± 5.8 | 13.9 ± 4.7 | 0.584 |
Post-procedural CK-MB (U/L) | 18.5 ± 10.4 | 14.2 ± 5.6 | 0.054 |
Pre-procedure troponin T (ng/ml) | 0.014 ± 0.018 | 0.016 ± 0.017 | 0.872 |
Post-procedure troponin T (ng/ml) | 0.015 ± 0.021 | 0.156 ± 0.291 | <0.01 |
Medication before angiography | |||
Beta-blocker (%) | 273 (82.0) | 177 (83.9) | 0.794 |
ACEI/ARB (%) | 229 (68.8) | 137 (64.9) | 0.588 |
Aspirin (%) | 301 (90.4) | 184 (87.2) | 0.536 |
Statin (%) | 314 (94.3) | 200 (94.8) | 0.921 |